NR4A1 and breast carcinoma: Using immunohistochemistry (IHC), the three hormone receptors for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) are first identified in breast cancer tumors to determine the type of breast cancer (4-6).